OIG - Office of Inspector General
09/30/2026 | Press release | Distributed by Public on 10/01/2026 06:54
Signal Diagnostics Agrees to Pay over $20M to Settle False Claims Act Allegations for Failing to Refund Overpayments to the HRSA Uninsured Program
Signal Diagnostics Agrees to Pay over $20M to Settle False Claims Act Allegations for Failing to Refund Overpayments to the HRSA Uninsured Program
Signal Diagnostics LLC (Signal) has agreed to pay the United States $20.5 million to resolve allegations that Signal violated the False Claims Act by knowingly retaining and improperly avoiding its obligations to repay the Health Resources & Services Administration (HRSA) COVID-19 Claims Reimbursement to Health Care Providers and Facilities for Testing, Treatment, and Vaccine Administration for the Uninsured Program (the "Uninsured Program") for overpayments for claims Signal submitted for patients who had health insurance.
Action Details
- Date:Sept. 30, 2026, 8:39 a.m.
- Agency:U.S. Department of Justice
-
Enforcement Types:
- COVID-19,
- Criminal and Civil Actions
OIG - Office of Inspector General published this content on September 30, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 01, 2026 at 12:54 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]